Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (285) clinical trials

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

The purpose of the trial is to test if the trial drug, tralokinumab, is better than placebo or ‘dummy treatment’ at treating moderate to severe atopic dermatitis. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis, itch and several other symptoms, ...

Phase

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

Phase

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Phase N/A

Physical exam and assessments of study condition to be provided at no cost by an experienced provider. No insurance necessary. Compensation will be provided at the end of study participation.  

Phase

This study will be testing an investigational drug for peanut allergies  

Phase

 In this study, you will get either MSTT1041A or placebo.  A placebo looks like a drug but has no active ingredient.   About 90 people will take part in this study. MSTT1041A is an experimental drug, which means that is being tested and is not approved for sale in the United ...

Phase

Primary objective is to assess whether dupilumab as adjunct to AR101 compared to placebo improves desensitization at the completion of up-dosing, defined as an increase in the proportion of participants who pass a double-blind placebo-controlled food challenge (DBPCFC) at week 28.

Phase

Atopic Dermatitis is a chronic medical condition that has increased over the past two to three decades. It affects between 15-30% of children and 2-10% of adults. Local physicians are currently evaluating a trial medication for Atopic Dermatitis to see if it may help symptoms. Find out more!  

Phase N/A